長期投資家のためのIR情報
バリュートレンド

【4570】免疫生物研究所
研究用試薬。
類似企業:

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/11/11 Q2予 925 0.0% 0.0% 120 0.0% 0.0% 120 0.0% 0.0% 115 0.0% 0.0%
2025.03 2024/08/08 Q1予 925 0.0% 0.0% 120 0.0% 0.0% 120 0.0% 0.0% 115 0.0% 0.0%
2025.03 2024/05/14 当初予 925 - - - 120 - - - 120 - - - 115 - - -
2024.03 2024/05/14 816 0.0% -4.0% 104 0.0% +15.6% 125 0.0% +38.9% 186 0.0% +132.5%
2024.03 2024/05/10 修正予 816 -4.0% -4.0% 104 +15.6% +15.6% 125 +38.9% +38.9% 186 +132.5% +132.5%
2024.03 2024/02/02 Q3予 850 0.0% 0.0% 90 0.0% 0.0% 90 0.0% 0.0% 80 0.0% 0.0%
2024.03 2023/11/02 Q2予 850 0.0% 0.0% 90 0.0% 0.0% 90 0.0% 0.0% 80 0.0% 0.0%
2024.03 2023/08/07 Q1予 850 0.0% 0.0% 90 0.0% 0.0% 90 0.0% 0.0% 80 0.0% 0.0%
2024.03 2023/05/12 当初予 850 - - - 90 - - - 90 - - - 80 - - -
2023.03 2023/05/12 794 0.0% +2.5% 58 0.0% +1833.3% -149 -17.3% -56.8% -289 0.0% -140.8%
2023.03 2023/04/27 修正予 794 +2.5% +2.5% 58 +1833.3% +1833.3% -127 -33.7% -33.7% -289 -140.8% -140.8%
2023.03 2023/02/06 Q3予 775 0.0% 0.0% 3 0.0% 0.0% -95 0.0% 0.0% -120 0.0% 0.0%
2023.03 2022/11/04 Q2予 775 0.0% 0.0% 3 0.0% 0.0% -95 0.0% 0.0% -120 0.0% 0.0%
2023.03 2022/08/05 Q1予 775 0.0% 0.0% 3 0.0% 0.0% -95 0.0% 0.0% -120 0.0% 0.0%
2023.03 2022/05/13 当初予 775 - - - 3 - - - -95 - - - -120 - - -
2022.03 2022/05/13 647 +0.3% -16.0% -122 +4.7% -14.0% -243 +1.2% -57.8% -258 -1.2% -59.3%
2022.03 2022/03/15 修正予 645 -16.2% -16.2% -128 -19.6% -19.6% -246 -59.7% -59.7% -255 -57.4% -57.4%
2022.03 2022/02/04 Q3予 770 0.0% 0.0% -107 0.0% 0.0% -154 0.0% 0.0% -162 0.0% 0.0%
2022.03 2021/11/05 Q2予 770 0.0% 0.0% -107 0.0% 0.0% -154 0.0% 0.0% -162 0.0% 0.0%
2022.03 2021/08/06 Q1予 770 0.0% 0.0% -107 0.0% 0.0% -154 0.0% 0.0% -162 0.0% 0.0%
2022.03 2021/05/14 当初予 770 - - - -107 - - - -154 - - - -162 - - -
2021.03 2021/05/14 602 +9.7% +9.7% -240 +22.1% +22.1% -310 +24.4% +24.4% -318 +26.0% +26.0%
2021.03 2021/02/12 Q3予 549 0.0% 0.0% -308 0.0% 0.0% -410 0.0% 0.0% -430 0.0% 0.0%
2021.03 2020/11/06 Q2予 549 0.0% 0.0% -308 0.0% 0.0% -410 0.0% 0.0% -430 0.0% 0.0%
2021.03 2020/08/07 Q1予 549 0.0% 0.0% -308 0.0% 0.0% -410 0.0% 0.0% -430 0.0% 0.0%
2021.03 2020/08/06 当初予 549 - - - -308 - - - -410 - - - -430 - - -
2020.03 2020/05/14 576 +1.9% -41.9% -595 +8.5% -52.2% -678 +7.1% -23.3% -668 +10.3% -18.2%
2020.03 2020/03/17 修正予 565 -15.7% -43.0% -650 -27.5% -66.2% -730 -14.1% -32.7% -745 -13.7% -31.9%
2020.03 2020/02/07 Q3予 670 0.0% -32.4% -510 0.0% -30.4% -640 0.0% -16.4% -655 0.0% -15.9%
2020.03 2019/11/08 Q2予 670 -32.4% -32.4% -510 -30.4% -30.4% -640 -16.4% -16.4% -655 -15.9% -15.9%
2020.03 2019/08/02 Q1予 991 0.0% 0.0% -391 0.0% 0.0% -550 0.0% 0.0% -565 0.0% 0.0%
2020.03 2019/05/14 当初予 991 - - - -391 - - - -550 - - - -565 - - -
2019.03 2019/05/14 781 +0.1% -20.5% -173 -15.3% -592.0% -155 -15.7% -545.8% -167 -11.3% -328.2%
2019.03 2019/03/22 修正予 780 -20.6% -20.6% -150 -500.0% -500.0% -134 -458.3% -458.3% -150 -284.6% -284.6%
2019.03 2019/02/01 Q3予 982 0.0% 0.0% -25 0.0% 0.0% -24 0.0% 0.0% -39 0.0% 0.0%
2019.03 2018/11/05 Q2予 982 0.0% 0.0% -25 0.0% 0.0% -24 0.0% 0.0% -39 0.0% 0.0%
2019.03 2018/08/03 Q1予 982 0.0% 0.0% -25 0.0% 0.0% -24 0.0% 0.0% -39 0.0% 0.0%
2019.03 2018/05/14 当初予 982 - - - -25 - - - -24 - - - -39 - - -
2018.03 2018/05/14 758 +1.7% -1.9% -48 +31.4% +58.6% -49 +34.7% +59.8% -52 +33.3% +59.4%
2018.03 2018/03/16 修正予 745 -3.6% -3.6% -70 +39.7% +39.7% -75 +38.5% +38.5% -78 +39.1% +39.1%
2018.03 2018/02/02 Q3予 773 0.0% 0.0% -116 0.0% 0.0% -122 0.0% 0.0% -128 0.0% 0.0%
2018.03 2017/11/02 Q2予 773 0.0% 0.0% -116 0.0% 0.0% -122 0.0% 0.0% -128 0.0% 0.0%
2018.03 2017/08/04 Q1予 773 0.0% 0.0% -116 0.0% 0.0% -122 0.0% 0.0% -128 0.0% 0.0%
2018.03 2017/05/12 当初予 773 - - - -116 - - - -122 - - - -128 - - -
2017.03 2017/05/12 741 0.0% -7.4% -1,156 0.0% -542.2% -1,170 0.0% -550.0% -2,094 0.0% -1002.1%
2017.03 2017/05/10 修正予 741 -7.4% -7.4% -1,156 -542.2% -542.2% -1,170 -550.0% -550.0% -2,094 -1002.1% -1002.1%
2017.03 2017/02/03 Q3予 800 0.0% 0.0% -180 0.0% 0.0% -180 0.0% 0.0% -190 0.0% 0.0%
2017.03 2016/11/04 Q2予 800 0.0% 0.0% -180 0.0% 0.0% -180 0.0% 0.0% -190 0.0% 0.0%
2017.03 2016/08/04 Q1予 800 0.0% 0.0% -180 0.0% 0.0% -180 0.0% 0.0% -190 0.0% 0.0%
2017.03 2016/05/13 当初予 800 - - - -180 - - - -180 - - - -190 - - -
2016.03 2016/05/13 717 0.0% -20.3% -75 0.0% -114.3% -81 0.0% -62.0% -31 0.0% -255.0%
2016.03 2016/05/09 修正予 717 -1.8% -20.3% -75 +34.8% -114.3% -81 +32.5% -62.0% -31 +43.6% -255.0%
2016.03 2016/02/05 Q3予 730 0.0% -18.9% -115 0.0% -228.6% -120 0.0% -140.0% -55 0.0% -375.0%
2016.03 2015/11/06 Q2予 730 -18.9% -18.9% -115 -228.6% -228.6% -120 -140.0% -140.0% -55 -375.0% -375.0%
2016.03 2015/08/04 Q1予 900 - - - -35 - - - -50 - - - 20 - - -
2015.03 2015/02/06 Q3予 700 0.0% -22.2% -170 0.0% -1800.0% -140 0.0% -1500.0% -150 0.0% -5100.0%
2015.03 2014/12/19 修正予 700 -22.2% -22.2% -170 -1800.0% -1800.0% -140 -1500.0% -1500.0% -150 -5100.0% -5100.0%
2015.03 2014/11/07 Q2予 900 0.0% 0.0% 10 0.0% 0.0% 10 0.0% 0.0% 3 0.0% 0.0%
2015.03 2014/08/05 Q1予 900 0.0% 0.0% 10 0.0% 0.0% 10 0.0% 0.0% 3 0.0% 0.0%
2015.03 2014/05/13 当初予 900 - - - 10 - - - 10 - - - 3 - - -
2014.03 2014/05/13 670 0.0% 0.0% -107 0.0% 0.0% -99 0.0% 0.0% -114 0.0% 0.0%
2014.03 2014/05/02 当初予 670 - - - -107 - - - -99 - - - -114 - - -
ページトップへ戻る